Stockreport

FDA requires clinical study to support PAVmed's CarpX application; shares down 26% premarket [Seeking Alpha]

PAVmed Inc.  (PAVM) 
US:NASDAQ Investor Relations: ir.pavm.com
PDF FDA requires clinical study to support PAVmed's CarpX application; shares down 26% premarket [Read more]